Cardiovascular Disease

PACT provides education, leadership & production assistance to the cell therapy community through contract manufacturing of therapeutic cell products.

The PEAR study is designed to evaluate 800 randomized subjects with a history of hypertension controlled by medication.

The BPCA DCC supports multiple clinical trials involving exclusively infants and children designed to improve labeling of drugs for pediatric use.